Literature DB >> 21926606

Impact of case volume on survival of septic shock in patients with malignancies.

Benjamin Zuber1, Thi-Chien Tran, Philippe Aegerter, David Grimaldi, Julien Charpentier, Bertrand Guidet, Jean-Paul Mira, Frédéric Pène.   

Abstract

OBJECTIVE: Septic shock is a frequent and severe complication in the course of malignancies. In a large multicenter cohort of septic shock patients with hematologic malignancies and solid tumors, we assessed the temporal trend in survival and the prognostic factors, with particular emphasis on case volume.
DESIGN: A 12-yr multicenter retrospective cohort study of prospectively collected data. PATIENTS AND METHODS: Cancer patients with septic shock were selected over a 12-yr period (1997-2008) from a French regional database (CUB-Réa). The following variables were extracted: demographic characteristics, type of malignancy, characteristics of infection, severity-of-illness score (Simplified Acute Physiology Score II), organ failure supports, and vital status. For each unit, a running mean annual volume of admissions was calculated for the purpose of categorization into volume tertiles. Prognostic factors were analyzed by a conditional multivariate logistic model after matching on a propensity score of being admitted to a high-volume unit and on the year of admission.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: A total of 3,437 patients were included in the study. The intensive care unit mortality rate dramatically dropped over time (from 70.4% in 1997 to 52.5% in 2008, relative decrease 25.4%, p < .001). Participating units were distributed into low-volume (< five patients per year), medium-volume (five to 12 patients per year), and high-volume (≥ 13 patients per year) tertiles. A medical cause for intensive care unit admission, Simplified Acute Physiology Score II, invasive mechanical ventilation, renal replacement therapy, fungal infections, and unknown microorganism were identified as poor prognostic factors. Case volume demonstrated a strong influence on survival, admission in a high-volume unit being associated with a marked decrease in mortality as compared to low-volume units (adjusted odds ratio 0.63; 95% confidence interval [0.46-0.87], p = .002).
CONCLUSIONS: Survival of septic shock patients with malignancies markedly increased over the recent years. Furthermore, we identified case volume as a major prognostic factor in this setting.

Entities:  

Mesh:

Year:  2012        PMID: 21926606     DOI: 10.1097/CCM.0b013e31822d74ba

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  42 in total

Review 1.  The Volume-Outcome Relationship in Critical Care: A Systematic Review and Meta-analysis.

Authors:  Yên-Lan Nguyen; David J Wallace; Youri Yordanov; Ludovic Trinquart; Josefin Blomkvist; Derek C Angus; Jeremy M Kahn; Philippe Ravaud; Bertrand Guidet
Journal:  Chest       Date:  2015-07       Impact factor: 9.410

2.  [Hematopoietic stem cell transplantation: bone marrow and blood stem cells].

Authors:  M von Bergwelt-Baildon; U Holtick; M J Hallek; C Scheid
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

3.  Improved outcome of critically ill patients with hematological malignancies: what's next?

Authors:  Ayman O Soubani; Johan Decruyenaere
Journal:  Intensive Care Med       Date:  2014-08-01       Impact factor: 17.440

4.  Has survival increased in cancer patients admitted to the ICU? Yes.

Authors:  Djamel Mokart; Stephen M Pastores; Michael Darmon
Journal:  Intensive Care Med       Date:  2014-08-27       Impact factor: 17.440

5.  Has survival increased in cancer patients admitted to the ICU? We are not sure.

Authors:  Dominique D Benoit; Marcio Soares; Elie Azoulay
Journal:  Intensive Care Med       Date:  2014-09-13       Impact factor: 17.440

Review 6.  The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.

Authors:  Elie Azoulay; Peter Schellongowski; Michael Darmon; Philippe R Bauer; Dominique Benoit; Pieter Depuydt; Jigeeshu V Divatia; Virginie Lemiale; Maarten van Vliet; Anne-Pascale Meert; Djamel Mokart; Stephen M Pastores; Anders Perner; Frédéric Pène; Peter Pickkers; Kathryn A Puxty; Francois Vincent; Jorge Salluh; Ayman O Soubani; Massimo Antonelli; Thomas Staudinger; Michael von Bergwelt-Baildon; Marcio Soares
Journal:  Intensive Care Med       Date:  2017-07-19       Impact factor: 17.440

7.  Long-term outcomes and quality of life in critically ill patients with hematological or solid malignancies: a single center study.

Authors:  S G Oeyen; D D Benoit; L Annemans; P O Depuydt; S J Van Belle; R I Troisi; L A Noens; P Pattyn; J M Decruyenaere
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

8.  Management of Acute Respiratory Failure in Patients With Hematological Malignancy.

Authors:  Rakesh Vadde; Stephen M Pastores
Journal:  J Intensive Care Med       Date:  2016-07-07       Impact factor: 3.510

Review 9.  [Chronic critically ill patients from the perspective of hematologists/oncologists].

Authors:  T Staudinger; P Schellongowski
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-02-28       Impact factor: 0.840

10.  Acute kidney injury in critically ill patients with haematological malignancies: results of a multicentre cohort study from the Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie.

Authors:  Michael Darmon; François Vincent; Emmanuel Canet; Djamel Mokart; Frédéric Pène; Achille Kouatchet; Julien Mayaux; Martine Nyunga; Fabrice Bruneel; Antoine Rabbat; Christine Lebert; Pierre Perez; Anne Renault; Anne-Pascale Meert; Dominique Benoit; Rebecca Hamidfar; Mercé Jourdain; Benoit Schlemmer; Sylvie Chevret; Virginie Lemiale; Elie Azoulay
Journal:  Nephrol Dial Transplant       Date:  2015-12       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.